Feasibility Study Using Zone-MPC Controller, HMS and Technosphere® Insulin Inhalation System From MannnKind Corp

NCT01874392 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Type 1 Diabetes Mellitus

Interventions

DRUG: Investigational inhaled insulin (Technosphere)
DEVICE: Artificial Pancreas (AP) device (APS©)

Sponsor

Sansum Diabetes Research Institute

Collaborators

[object Object]